Ling Xiao
机构:Hunan University of Science and Technology, Joslin Diabetes Center, Beth Israel Deaconess Medical Center, Harvard University, Central South University, University of Electronic Science and Technology of China, Hadassah Medical Center, ShanghaiTech University, Wuhan University, Wuhan Institute of Bioengineering, Zhongnan Hospital of Wuhan University, Harvard Stem Cell Institute, Zhejiang University · ORCID:0000-0002-7439-0289
发表论文 66 篇 · 总被引 1403 次 · h-index 18
代表论文
- Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges (2025 · Molecular Cancer · 被引 77)
- Redox regulation of m6A methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes (2024 · Nature Cell Biology · 被引 53)
- m6A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1 (2024 · Cell Metabolism · 被引 26)
- ADSL promotes autophagy and tumor growth through fumarate-mediated Beclin1 dimethylation (2025 · Nature Chemical Biology · 被引 23)
- Single-nucleus transcriptomic analysis reveals the relationship between gene expression in oligodendrocyte lineage and major depressive disorder (2024 · Journal of Translational Medicine · 被引 20)
- Divergent roles of m6A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism (2025 · Nature Communications · 被引 16)